In the TCGA study13, the comprehensive genomic analysis of 333 primary PCa cases revealed that the majority of tumors (74%) fell into one of seven subtypes defined by specific gene fusions (ERG, ETV1/4, FLI1) or mutations (SPOP, FOXA1, IDH1). The gene discussed is IDH1; the disease is posterior cortical atrophy.